Recombinant NKG2A (Monalizumab Biosimilar) antibody
The Humanized Monoclonal anti-NKG2A (Monalizumab Biosimilar) antibody is suitable to detect NKG2A (Monalizumab Biosimilar) in samples from Human. It has been validated for FACS.
Catalog No. ABIN7490930
-15% Promotion 2026
$248.57
save $43.86 (-15 %)
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 12 to 14 Business Days
Quick Overview for Recombinant NKG2A (Monalizumab Biosimilar) antibody (ABIN7490930)
Target
NKG2A (Monalizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Conjugate
This NKG2A (Monalizumab Biosimilar) antibody is un-conjugated
Application
Flow Cytometry (FACS)
Grade
Research Grade
-
-
Purpose
- Anti-NKG2A (monalizumab biosimilar) mAb
-
Characteristics
- IPH-2201, IPH2201, NN-8765, NNC-0141-0000-0100, NNC-141-01000, anti-NKG2A, humZ270
-
Purification
- Purified from cell culture supernatant by affinity chromatography
-
Isotype
- IgG4
-
-
-
-
Application Notes
- Flow Cyt 1:100
-
Comment
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitute with deionized water
-
Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
Expiry Date
- 12 months
-
-
- NKG2A (Monalizumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- Synonyms: CD159A, NKG2, NKG2A
-
UniProt
- P26715
Target
-
You are here:
